<DOC>
	<DOC>NCT01112020</DOC>
	<brief_summary>The purpose of this study is to determine the contents of a chlorhexidine-containing dressing after use.</brief_summary>
	<brief_title>Components of Chlorhexidine Gluconate Dressing</brief_title>
	<detailed_description>To characterize the chemical composition of the CHG (2% CHG) Catheter Dressing Patch as compared to Biopatch Protective Disk with CHG, and Tegaderm IV (intravenous) Securement Dressing over a wear period of 7 days.</detailed_description>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Able to read, review and sign the Informed Consent Willing to shower using the same soap/cleansers from the Screening Visit through the end of the study Use studyapproved contraceptive methods Participation in an investigational study within 28 days prior to dosing. Clinically significant illness within 28 days prior to dosing. History of allergic responses to chlorhexidine, chlorhexidinecontaining products, glycerol, adhesives, latex History of clinically significant skin disorders History of Type I diabetes mellitus, insulindependent diabetes mellitus(IDDM) History of significant dermatologic cancers (melanoma, squamous) Known history of immunologic disorders Use immunosuppressive or other proscribed medications Use of skin products at the application site Significant history of allergies to soaps, lotions, emollients, ointments, creams History of drug or alcohol addiction within the past year Pregnant, lactating, breastfeeding, or intends to become pregnant during the course of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Chlorhexidine digluconate (CHG)</keyword>
	<keyword>Biopatch Protective Disk</keyword>
	<keyword>Tegaderm CHG IV (intravenous) Securement Dressing</keyword>
	<keyword>parachloroaniline (PCA)</keyword>
	<keyword>No condition being studied.</keyword>
	<keyword>Assessing components of CHG-containing dressings after use.</keyword>
</DOC>